A Pfizer vaccine to protect older adults and infants from respiratory syncytial virus (RSV) infection has shown what some scientists are calling “exciting” promise in late-stage...
An vaccine for respiratory syncytial virus (RSV) is 82% effective in babies when given to pregnant mothers, according to data released Wednesday after a spike...
While this was the only vote at ACIP’s February 22-24 meeting, the committee also discussed COVID-19 booster vaccines for specific patient populations and updated vaccines for...
The United States and many countries around the world were caught off guard by the rapid rise in RSV infections. An almost routine explanation, many attribute...
February 7, 2023 – About 40% of U.S. households had at least one person sick with a trio of respiratory illnesses called triple demics during the...
According to the Centers for Disease Control and Prevention (CDC), seasonal influenza activity continues to decline in much of the United States. Most states had “minimal”...
Recent Comments